该产品被引用文献
1, Amanat, F; et al. SARS-CoV-2 mRNA vaccination induces functionally diverse antibodies to NTD, RBD, and S2. Cell
2, Tong, P; et al. Memory B cell repertoire for recognition of evolving SARS-CoV-2 spike. Cell, Pubmed: 34332650
3, Kramer, KJ; et al. Potent neutralization of SARS-CoV-2 variants of concern by an antibody with an uncommon genetic signature and structural mode of spike recognition. Cell reports, Pubmed: 34592170
4, Chen, Y; et al. Immune recall improves antibody durability and breadth to SARS-CoV-2 variants. Science immunology, Pubmed: 35549298
5, Wang, M; et al. A key F27I substitution within HCDR1 facilitates the rapid maturation of P2C-1F11-like neutralizing antibodies in a SARS-CoV-2-infected donor. Cell Reports
6, Langel, SN; et al. Dam-Infant Rhesus Macaque Pairs to Dissect Age-Dependent Responses to SARS-CoV-2 Infection. ImmunoHorizons, Pubmed: 36547390
7, Carreño, JM; et al. An inactivated NDV-HXP-S COVID-19 vaccine elicits a higher proportion of neutralizing antibodies in humans than mRNA vaccination. Science translational medicine, Pubmed: 36791207
8, Jia, T; et al. Stable and durable antibody responses in SARS-recovered donors vaccinated with inactivated SARS-CoV-2 vaccine. Journal of medical virology, Pubmed: 36905115
9, Amanat, F. In Depth Characterization of Immune Response Against the Spike Protein of Sars-CoV-2 in Response to Infection and mRna Vaccination. Thesis